Evidence map›Paper›PMID 36038109›Full record

ArticleBiomedical journal2023

Hypocalcemia: A key biomarker in hospitalized COVID-19 patients.

María Jesús Ruiz-Álvarez, Emanuela Stampone, Yaiza Fernández Verduras, Giovanni Gallo, Marta Barrionuevo González, Belén Beteré Cubillo, Debora Bencivenga, Fulvio Della Ragione, Adriana Borriello

Open access · goldAbstract read
In one paragraph

Article in Biomedical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Down to earth - A new type of hygiene.Biomedical journal · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

María Jesús Ruiz-ÁlvarezDepartment of Clinical Chemistry, University Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Emanuela StamponeDepartment of Precision Medicine, University of Campania "L. Vanvitelli", via De Crecchio, Naples, Italy.
Yaiza Fernández VerdurasDepartment of Clinical Chemistry, University Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Giovanni GalloDepartment of Precision Medicine, University of Campania "L. Vanvitelli", via De Crecchio, Naples, Italy.
Marta Barrionuevo GonzálezDepartment of Clinical Chemistry, University Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Belén Beteré CubilloDepartment of Clinical Chemistry, University Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Debora BencivengaDepartment of Precision Medicine, University of Campania "L. Vanvitelli", via De Crecchio, Naples, Italy.
Fulvio Della RagioneDepartment of Precision Medicine, University of Campania "L. Vanvitelli", via De Crecchio, Naples, Italy.
Adriana BorrielloDepartment of Precision Medicine, University of Campania "L. Vanvitelli", via De Crecchio, Naples, Italy. Electronic address: adriana.borriello@unicampania.it.
University of Campania "Luigi Vanvitelli" · ITHospital Universitario Príncipe de Asturias · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAt the end of 2019 a new respiratory syndrome emerged in China named Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 infection. Considering the severity of the disease in adult subjects with one or more chronic pathologies, it was mandatory to find simple and effective biomarkers for negative prognosis of the disease easily available at the admission to the hospital.

methodsTo identify possible parameters showing association with the outcome in COVID-19 patients with pre-existing chronic diseases, blood biochemical profiles of 511 patients, enrolled from March to June 2020, were retrospectively evaluated. The pathological conditions taken into consideration were diabetes, arterial hypertension, chronic kidney disease, cardiovascular diseases, chronic obstructive pulmonary disease, obesity, and cancer. All the data were collected upon admission to the emergency room (ER) during the indicated period.

resultsWe observed that serum and ionized calcium were prevalently altered in our cohort. We determined that hypocalcemia was a major parameter associated with mechanical ventilation and poor prognosis, correlating also with the presence of comorbidities such as cardiovascular diseases, chronic kidney disease, and cancer. In addition, we found a positive correlation between hypocalcemia and clinical complications during hospitalizations.

conclusionsOur results strengthen the relevance of serum calcium concentration as a useful prognostic biomarker in hospitalized COVID-19 patients.

Indexed as

Cardiovascular DiseasesCOVID-19HypocalcemiaAdultBiomarkersCalciumHumansRetrospective StudiesSARS-CoV-2BiomarkersCalciumCalciumCKDCOVID-19CVDHypocalcemiaSARS-CoV-2

Identifiers

PMID36038109
PMCPMC9420312
OpenAlexW4293393308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.